Logo image of CNTY

CENTURY CASINOS INC (CNTY) Stock Fundamental Analysis

NASDAQ:CNTY - Nasdaq - US1564921005 - Common Stock - Currency: USD

2.32  +0.01 (+0.43%)

After market: 2.23 -0.09 (-3.88%)

Fundamental Rating

2

Taking everything into account, CNTY scores 2 out of 10 in our fundamental rating. CNTY was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of CNTY have multiple concerns. CNTY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CNTY has reported negative net income.
In the past year CNTY had a positive cash flow from operations.
In multiple years CNTY reported negative net income over the last 5 years.
Of the past 5 years CNTY 4 years had a positive operating cash flow.
CNTY Yearly Net Income VS EBIT VS OCF VS FCFCNTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.15%, CNTY is doing worse than 86.57% of the companies in the same industry.
CNTY has a Return On Invested Capital of 3.29%. This is in the lower half of the industry: CNTY underperforms 64.93% of its industry peers.
CNTY had an Average Return On Invested Capital over the past 3 years of 4.52%. This is significantly below the industry average of 14.01%.
Industry RankSector Rank
ROA -11.15%
ROE N/A
ROIC 3.29%
ROA(3y)-3.87%
ROA(5y)-3.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.52%
ROIC(5y)5.13%
CNTY Yearly ROA, ROE, ROICCNTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

With a Operating Margin value of 8.22%, CNTY perfoms like the industry average, outperforming 47.01% of the companies in the same industry.
CNTY's Operating Margin has improved in the last couple of years.
The Gross Margin of CNTY (44.56%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CNTY has remained more or less at the same level.
Industry RankSector Rank
OM 8.22%
PM (TTM) N/A
GM 44.56%
OM growth 3Y-22.08%
OM growth 5Y1.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.38%
GM growth 5Y-1.02%
CNTY Yearly Profit, Operating, Gross MarginsCNTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNTY is destroying value.
Compared to 1 year ago, CNTY has more shares outstanding
CNTY has more shares outstanding than it did 5 years ago.
CNTY has a worse debt/assets ratio than last year.
CNTY Yearly Shares OutstandingCNTY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNTY Yearly Total Debt VS Total AssetsCNTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CNTY has an Altman-Z score of 0.51. This is a bad value and indicates that CNTY is not financially healthy and even has some risk of bankruptcy.
CNTY's Altman-Z score of 0.51 is on the low side compared to the rest of the industry. CNTY is outperformed by 75.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACC0.44
WACC7.49%
CNTY Yearly LT Debt VS Equity VS FCFCNTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CNTY has a Current Ratio of 1.42. This is a normal value and indicates that CNTY is financially healthy and should not expect problems in meeting its short term obligations.
CNTY's Current ratio of 1.42 is fine compared to the rest of the industry. CNTY outperforms 70.90% of its industry peers.
A Quick Ratio of 1.38 indicates that CNTY should not have too much problems paying its short term obligations.
CNTY's Quick ratio of 1.38 is fine compared to the rest of the industry. CNTY outperforms 73.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.38
CNTY Yearly Current Assets VS Current LiabilitesCNTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The earnings per share for CNTY have decreased strongly by -122.39% in the last year.
Looking at the last year, CNTY shows a decrease in Revenue. The Revenue has decreased by -1.28% in the last year.
The Revenue has been growing by 21.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-122.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.89%
Revenue 1Y (TTM)-1.28%
Revenue growth 3Y14.02%
Revenue growth 5Y21.42%
Sales Q2Q%-4.1%

3.2 Future

The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
CNTY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.26% yearly.
EPS Next Y54.15%
EPS Next 2Y31.16%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue Next Year1.75%
Revenue Next 2Y4.11%
Revenue Next 3Y4.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNTY Yearly Revenue VS EstimatesCNTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CNTY Yearly EPS VS EstimatesCNTY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNTY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNTY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTY Price Earnings VS Forward Price EarningsCNTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

CNTY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CNTY is cheaper than 64.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.53
CNTY Per share dataCNTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CNTY's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.16%
EPS Next 3Y24.9%

0

5. Dividend

5.1 Amount

CNTY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURY CASINOS INC

NASDAQ:CNTY (6/17/2025, 6:09:59 PM)

After market: 2.23 -0.09 (-3.88%)

2.32

+0.01 (+0.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners51.44%
Inst Owner Change-2.25%
Ins Owners10.62%
Ins Owner Change0%
Market Cap71.18M
Analysts84
Price Target3.83 (65.09%)
Short Float %0.58%
Short Ratio1.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.62%
Min EPS beat(2)-32.99%
Max EPS beat(2)-30.24%
EPS beat(4)0
Avg EPS beat(4)-106.3%
Min EPS beat(4)-356.62%
Max EPS beat(4)-5.33%
EPS beat(8)1
Avg EPS beat(8)-135.89%
EPS beat(12)2
Avg EPS beat(12)-185.72%
EPS beat(16)4
Avg EPS beat(16)-106.15%
Revenue beat(2)0
Avg Revenue beat(2)-6.69%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)-5.02%
Revenue beat(4)0
Avg Revenue beat(4)-5.14%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)-1.85%
Revenue beat(8)2
Avg Revenue beat(8)-2.82%
Revenue beat(12)2
Avg Revenue beat(12)-2.44%
Revenue beat(16)5
Avg Revenue beat(16)-0.92%
PT rev (1m)-21.05%
PT rev (3m)-37.5%
EPS NQ rev (1m)-11.21%
EPS NQ rev (3m)-174.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-80.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 20.02
P/B N/A
P/tB N/A
EV/EBITDA 10.53
EPS(TTM)-2.98
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)0.12
OCFY5%
SpS18.59
BVpS-0.94
TBVpS-4.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.15%
ROE N/A
ROCE 4.16%
ROIC 3.29%
ROICexc 3.55%
ROICexgc 4.02%
OM 8.22%
PM (TTM) N/A
GM 44.56%
FCFM N/A
ROA(3y)-3.87%
ROA(5y)-3.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.52%
ROIC(5y)5.13%
ROICexc(3y)5.13%
ROICexc(5y)5.92%
ROICexgc(3y)5.77%
ROICexgc(5y)6.66%
ROCE(3y)5.73%
ROCE(5y)6.49%
ROICexcg growth 3Y-28.69%
ROICexcg growth 5Y10.01%
ROICexc growth 3Y-28.84%
ROICexc growth 5Y11.19%
OM growth 3Y-22.08%
OM growth 5Y1.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.38%
GM growth 5Y-1.02%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.59
Cap/Depr 95.13%
Cap/Sales 8.33%
Interest Coverage 0.49
Cash Conversion 3.67%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.38
Altman-Z 0.51
F-Score3
WACC7.49%
ROIC/WACC0.44
Cap/Depr(3y)111.83%
Cap/Depr(5y)82.65%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-48.89%
EPS Next Y54.15%
EPS Next 2Y31.16%
EPS Next 3Y24.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.28%
Revenue growth 3Y14.02%
Revenue growth 5Y21.42%
Sales Q2Q%-4.1%
Revenue Next Year1.75%
Revenue Next 2Y4.11%
Revenue Next 3Y4.26%
Revenue Next 5YN/A
EBIT growth 1Y-11.31%
EBIT growth 3Y-11.16%
EBIT growth 5Y23.53%
EBIT Next Year-2.96%
EBIT Next 3Y16.02%
EBIT Next 5YN/A
FCF growth 1Y-515.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.67%
OCF growth 3YN/A
OCF growth 5YN/A